August 7th 2024
Why is it important for organizations to set long-term goals when planning for a sustainable future?
July 24th 2024
A deep dive into why this therapy has demonstrated effectiveness in various areas, including for tumors.
July 17th 2024
How teamwork among safety-net healthcare providers and pharma can make the difference.
June 7th 2024
Causal mediation analysis sought to determine how public hesitancy plays a role in the government procurement of certain vaccines.
May 30th 2024
These advancements continue to act as a key driver in helping to boost the security, efficiency, and innovation of global industries, include pharma.
No surprise here: FDA drug oversight is now a 'high risk' government operation
FDA’s management of drug and device safety enters GAO’s biennial watch list
Leading in Challenging Times
It has been said that one should never miss an opportunity to make the most of a crisis. The steady stream of headlines announcing staff cuts, delays in drug approvals and a narrowing of R&D focus for pharmaceutical and biotech companies indicate there will be no shortage of opportunities in 2009.
Specialty Pharmaceuticals and the Emergence of Sub-Specialty Pharmacy
‘Ultra-orphan’ diseases will alter the specialty distribution process